Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online May 1, 2023.
Copyright & Usage
Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.
Author Information
- Pauline Funchain, MD⇑
- Co-Director, Comprehensive Melanoma and High-Risk Cancer Program, Director, Melanoma Medical Oncology, Taussig Cancer Institute, and Co-Founder and Co-Director of Management of Checkpoint Inhibitor Toxicity, Cleveland Clinic; Associate Staff, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH; Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Panel Member, American Society of Clinical Oncology Guidelines on Immune-Related Adverse Events
- Address:
Pauline Funchain, MD, Department of Hematology and Medical Oncology, CA-60, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; funchap{at}ccf.org